Stay updated on Odevixibat for Biliary Atresia Post-Kasai Clinical Trial
Sign up to get notified when there's something new on the Odevixibat for Biliary Atresia Post-Kasai Clinical Trial page.

Latest updates to the Odevixibat for Biliary Atresia Post-Kasai Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov record for the completed Phase 3 odevixibat study in children with biliary atresia is displayed, including study design, eligibility, outcomes, and locations. It also provides information about sharing individual participant data.SummaryDifference77%

- Check7 days agoChange DetectedThe footer revision label was updated from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedA banner announces that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” across NIH content. The clinical trial record remains unavailable behind a 403 error.SummaryDifference1%

- Check21 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check49 days agoChange DetectedRevision: v3.7.0 appears on the page, marking a version update. The core trial details and user-facing content appear unchanged.SummaryDifference17%

Stay in the know with updates to Odevixibat for Biliary Atresia Post-Kasai Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Odevixibat for Biliary Atresia Post-Kasai Clinical Trial page.